Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3326
PUT
Avantor
AVTR
$10.7B
| $942K | ﹤0.01% |
+70,000
| New | +$958K |
2025 Q2
0 quarters
|
|
3327
Axogen
AXGN
$2.18B
| $940K | ﹤0.01% |
86,665
+21,913
| +34% | +$287K |
2017 Q1
33 quarters
|
|
3328
Elbit Systems
ESLT
$33.2B
| $939K | ﹤0.01% |
+2,090
| New | +$848K |
2025 Q2
0 quarters
|
|
3329
CALL
Baker Hughes
BKR
$57B
| $939K | ﹤0.01% |
+24,500
| New | +$925K |
2025 Q2
0 quarters
|
|
3330
Greene County Bancorp
GCBC
$584M
| $937K | ﹤0.01% |
42,188
+29,697
| +238% | +$658K |
2022 Q2
12 quarters
|
|
|
HOUS
3331
DELISTED
Anywhere Real Estate
HOUS
| $936K | ﹤0.01% |
258,524
+90,872
| +54% | +$317K |
2013 Q2
48 quarters
|
|
3332
Orthofix Medical
OFIX
$387M
| $936K | ﹤0.01% |
83,913
-19,421
| -19% | -$241K |
2013 Q4
46 quarters
|
|
3333
PUT
Capricor Therapeutics
CAPR
$452M
| $934K | ﹤0.01% |
+94,100
| New | +$994K |
2025 Q2
0 quarters
|
|
3334
Nature's Sunshine
NATR
$218M
| $932K | ﹤0.01% |
63,041
+26,851
| +74% | +$363K |
2016 Q1
37 quarters
|
|
|
CTO
3335
CTO Realty Growth
CTO
$761M
| $932K | ﹤0.01% |
53,990
-4,157
| -7% | -$75.2K |
2022 Q1
13 quarters
|
|
3336
Aveanna Healthcare
AVAH
$2.7B
| $931K | ﹤0.01% |
177,993
+62,450
| +54% | +$317K |
2022 Q1
13 quarters
|
|
3337
The RealReal
REAL
$1.13B
| $927K | ﹤0.01% |
193,519
+68,842
| +55% | +$379K |
2023 Q3
7 quarters
|
|
3338
Thryv Holdings
THRY
$66.2M
| $926K | ﹤0.01% |
76,151
+20,098
| +36% | +$260K |
2022 Q1
13 quarters
|
|
3339
Humacyte
HUMA
$139M
| $926K | ﹤0.01% |
442,979
+248,350
| +128% | +$477K |
2022 Q1
13 quarters
|
|
|
TSSI
3340
TSS Inc
TSSI
$284M
| $926K | ﹤0.01% |
+32,110
| New | +$422K |
2025 Q2
0 quarters
|
|
3341
CALL
Ollie's Bargain Outlet
OLLI
$5.16B
| $922K | ﹤0.01% |
+7,000
| New | +$801K |
2025 Q2
0 quarters
|
|
3342
Personalis
PSNL
$1.75B
| $921K | ﹤0.01% |
140,378
+54,387
| +63% | +$252K |
2019 Q3
23 quarters
|
|
3343
iShares MSCI China ETF
MCHI
$5.98B
| $921K | ﹤0.01% |
16,711
-16,613
| -50% | -$882K |
2015 Q1
41 quarters
|
|
3344
Zevra Therapeutics
ZVRA
$635M
| $919K | ﹤0.01% |
104,351
-330,339
| -76% | -$2.68M |
2022 Q3
11 quarters
|
|
|
ILPT
3345
Industrial Logistics Properties Trust
ILPT
$475M
| $919K | ﹤0.01% |
201,958
-37,876
| -16% | -$125K |
2018 Q1
29 quarters
|
|
|
TERN
3346
DELISTED
Terns Pharmaceuticals
TERN
| $912K | ﹤0.01% |
244,637
-408,400
| -63% | -$1.28M |
2022 Q1
13 quarters
|
|
|
SAGE
3347
DELISTED
Sage Therapeutics
SAGE
| $909K | ﹤0.01% |
99,618
+40,031
| +67% | +$294K |
2014 Q4
42 quarters
|
|
3348
Graham Corp
GHM
$1.06B
| $906K | ﹤0.01% |
18,308
+6,222
| +51% | +$231K |
2023 Q3
7 quarters
|
|
3349
The RMR Group
RMR
$298M
| $906K | ﹤0.01% |
55,413
+9,984
| +22% | +$153K |
2019 Q1
25 quarters
|
|
|
FPI
3350
Farmland Partners
FPI
$486M
| $906K | ﹤0.01% |
78,709
+20,281
| +35% | +$217K |
2017 Q1
33 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.